Year |
Citation |
Score |
2020 |
Ye X, Waite JC, Dhanik A, Gupta N, Zhong M, Adler C, Malahias E, Ni M, Wei Y, Gurer C, Zhang W, Macdonald LE, Murphy AJ, Sleeman MA, Skokos D. Endogenous retroviral proteins provide an immunodominant but not requisite antigen in a murine immunotherapy tumor model. Oncoimmunology. 9: 1758602. PMID 32923116 DOI: 10.1080/2162402X.2020.1758602 |
0.323 |
|
2020 |
Waite JC, Wang B, Haber L, Hermann A, Ullman E, Ye X, Dudgeon D, Slim R, Ajithdoss DK, Godin SJ, Ramos I, Wu Q, Oswald E, Poon P, Golubov J, ... ... Gurer C, et al. Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy. Science Translational Medicine. 12. PMID 32581132 DOI: 10.1126/Scitranslmed.Aba2325 |
0.307 |
|
2019 |
Gao J, Van Meter M, Lopez SH, Chen G, Huang Y, Ren S, Zhao Q, Rojas J, Gurer C, Thurston G, Kuhnert F. Therapeutic targeting of Notch signaling and immune checkpoint blockade in a spontaneous, genetically-heterogeneous mouse model of T-cell acute lymphoblastic leukemia. Disease Models & Mechanisms. PMID 31399482 DOI: 10.1242/Dmm.040931 |
0.311 |
|
2018 |
Wang B, Zhang W, Jankovic V, Golubov J, Poon P, Oswald EM, Gurer C, Wei J, Ramos I, Wu Q, Waite J, Ni M, Adler C, Wei Y, Macdonald L, et al. . Science Immunology. 3. PMID 30389797 DOI: 10.1126/Sciimmunol.Aat7061 |
0.345 |
|
2017 |
Herndler-Brandstetter D, Shan L, Yao Y, Stecher C, Plajer V, Lietzenmayer M, Strowig T, de Zoete MR, Palm NW, Chen J, Blish CA, Frleta D, Gurer C, Macdonald LE, Murphy AJ, et al. Humanized mouse model supports development, function, and tissue residency of human natural killer cells. Proceedings of the National Academy of Sciences of the United States of America. PMID 29078283 DOI: 10.1073/Pnas.1705301114 |
0.359 |
|
2017 |
Yu H, Borsotti C, Schickel JN, Zhu S, Strowig T, Eynon EE, Frleta D, Gurer C, Murphy AJ, Yancopoulos GD, Meffre E, Manz MG, Flavell RA. A novel humanized mouse model with significant improvement of class- switched, antigen-specific antibody production. Blood. PMID 28077418 DOI: 10.1182/Blood-2016-04-709584 |
0.326 |
|
2015 |
Deng K, Pertea M, Rongvaux A, Wang L, Durand CM, Ghiaur G, Lai J, McHugh HL, Hao H, Zhang H, Margolick JB, Gurer C, Murphy AJ, Valenzuela DM, Yancopoulos GD, et al. Broad CTL response is required to clear latent HIV-1 due to dominance of escape mutations. Nature. 517: 381-5. PMID 25561180 DOI: 10.1038/Nature14053 |
0.519 |
|
2015 |
Crawford A, Vazzana K, VanValkenburgh J, Haber L, Principio J, Gurer C, Olson K, Smith E, Thurston G, Kirshner JR. Abstract A193: Fully human bispecific antibodies induce potent anti-tumor effects against prostate tumors in mice Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-A193 |
0.347 |
|
2009 |
Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, Cohen JI, Münz C. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. The Journal of Experimental Medicine. 206: 1423-34. PMID 19487422 DOI: 10.1084/Jem.20081720 |
0.414 |
|
2008 |
Gurer C, Strowig T, Brilot F, Pack M, Trumpfheller C, Arrey F, Park CG, Steinman RM, Münz C. Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. Blood. 112: 1231-9. PMID 18519810 DOI: 10.1182/Blood-2008-03-148072 |
0.419 |
|
2006 |
Heller KN, Gurer C, Münz C. Virus-specific CD4+ T cells: ready for direct attack. The Journal of Experimental Medicine. 203: 805-8. PMID 16549599 DOI: 10.1084/Jem.20060215 |
0.39 |
|
2005 |
Gurer C, Höglund A, Höglund S, Luban J. ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity. Journal of Virology. 79: 5557-67. PMID 15827170 DOI: 10.1128/Jvi.79.9.5557-5567.2005 |
0.599 |
|
2005 |
Gurer C, Berthoux L, Luban J. Covalent modification of human immunodeficiency virus type 1 p6 by SUMO-1. Journal of Virology. 79: 910-7. PMID 15613319 DOI: 10.1128/Jvi.79.2.910-917.2005 |
0.574 |
|
2003 |
Berthoux L, Towers GJ, Gurer C, Salomoni P, Pandolfi PP, Luban J. As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. Journal of Virology. 77: 3167-80. PMID 12584341 DOI: 10.1128/Jvi.77.5.3167-3180.2003 |
0.569 |
|
2002 |
Gurer C, Cimarelli A, Luban J. Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. Journal of Virology. 76: 4666-70. PMID 11932435 DOI: 10.1128/Jvi.76.9.4666-4670.2002 |
0.556 |
|
Show low-probability matches. |